Member spotlight: CoMoveIT, patient-driven mobility solutions for people with complex movement disorders

CoMoveIT is a striking example of how visionary ideas can be turned into life-changing innovations once the right technology becomes available. We spoke with CoMoveIT’s CTO, Sotirios Gakopoulos, about the Belgian company’s unique solution to improve the mobility of patients with complex movement disorders, like cerebral palsy.

In the early 2000s, Prof. Dr. Elegast Monbaliu was working as a therapist for people with complex movement disorders. He was struck by how much the involuntary movements of his patients restricted their ability to move around independently using standard mobility aids such as powered wheelchairs.

People with severe dyskinetic cerebral palsy, for example, would have a hard time operating the joystick that is typically used to control a powered wheelchair. This observation awakened his desire to develop a more suitable steering system to meet these people’s needs.

Member spotlight is published in partnership with the life science news platform BioVox. Please visit the BioVox website to read the rest of the article

Share this article

More news on this topic

Better together

and are joining forces in a brand new organization

The members of MEDVIA and flanders.bio have voted to merge their activities in the first half of 2025. With a united voice, we will champion the entire healthtech and biotech ecosystem on the regional, federal and European stage.

The merger allows MEDVIA and flanders.bio to align activities and deliver more powerful support for our collective members. We will achieve greater impact with more dynamic networking opportunities, better directed funding and increased efficiency, sharpening our focus in common areas and drafting strategic roadmaps for Flanders.